Did you know that some of the most intelligent people on the planet aren’t household names? Did you know that some of the most successful people in society today are unheard of or unknown? Yes, this is true and Dr. Mark McKenna is living and breathing example of this notion. Dr. Mark McKenna may be known to people that live and work in his immediate communities, but for the people who live life outside of this bubble, they don’t have a clue of who he is. This man is very talented, he has a huge heart, and he has conquered multiple industries at the same time.
Thanks to having an educational background in real estate, he has been able to help a plethora of people during and after Hurricane Katrina. This tropical storm devastated his hometown of New Orleans, Louisiana. Unlike other high-profile people in the area, this advocate and dedicated community servant has lived up to his own hype. Dr. Mark McKenna put together an effort to rebuild the city. Fortunately, he was able to help his local community by rebuilding low-to-moderate income housing for those who needed it. Though he lost many of his personal belongings and contacts, this extraordinary man pushed through the barriers in hopes of helping others who had lost the same things. This is a trait that can’t be taught. You either have it, or you don’t have it.
One of his most successful businesses is known as OVME. This is a medical aesthetic company, and it connects healthcare providers with aspiring individuals. This direct-to-consumer-platform has taken the industry by storm thanks to its technological-advancements. With its boutique type of vibe, OVME gives consumers the opportunity to choose between a number of high-quality, cosmetic services. Dr. Mark McKenna sure isn’t a household name, but he has done more for society than 98 percent of your favorite entertainers combined.
For More info: prweb.com/releases/2013/10/prweb11262449.htm
Amicus Therapeutics is a New Jersey based company located at One Cedar Brook Drive in Cranbury. Amicus is a biotechnology Company that designs therapies to create rare as well as Orphan type diseases.
Migalastat is a treatment created by Amicus Therapeutics that is used to treat Fabry Disease. Fabry Disease is a genetic lysosomal disease. This disease is quite rare and it is inherited. Inherited diseases can be much more difficult to treat due to the fact that you are dealing with genetic factors.
The researchers at Amicus Therapeutics are about to release a new Chaperone-Advanced Replacement Therapy. Chaperone Advanced Replacement Therapy is essentially an enzyme replace therapy for Fabry Disease.
Researchers at Amicus Therapeutics are committed to discovering new treatments useful therapies for rare debilitating diseases. Enzyme therapy is continually being researched and tested in an attempt to discover new and more sophisticated cures.
John Crowley is the Chairman and CEO of Amicus Therapeutics. John Crowley has a special connection to Amicus Therapeutics (Google Finance). Both of Mr. Crowley’s children were diagnosed with Pompe disease. Pompe Disease is a serious neuromuscular disorder that can sometimes be fatal. Mr. Crowley hopes that Amicus will one day discover a therapy that will help his two children.
Much has been written about John Crowley. Mr. Crowley has been featured many times in the Wall Street Journal. In addition, John Crowley has been talked about many times on the Bloomberg network. Mr. Crowley is a savvy businessman with many years experience within the biotech and pharmaceutical industry. Bradley Campbell is the Chief Operating Officer of Amicus.
Amicus is quite passionate about what they do as well as what they stand for. The researchers at Amicus Therapeutics work very hard and they take smart risks. In addition, Amicus supports disease communities as well as thier family members. Amicus feels they have a duty to help those suffering from rare diseases that are quite serious, even life threatening in some instances.
More about Amicus Therapeutics at https://www.indeed.com/q-Amicus-Therapeutics-l-Cranbury,-NJ-jobs.html